Document Dv4nLD9NNkmaDmx0yj02o2w0O

From: Sent: To: Subject: Attach: Matt Todd <ToddM@api.org> Friday, October 31,2003 8:57 PM (GMT) BHRC Oversight Committee (E-mail) <benzconsort-oc@listserve.api.org>; BHRC Technical Committee (E-mail) <benzconsort-tc@listserve.api.org>; BHRC Communications Committee (E-mail) <benzconsort-cc@listserve.api.org> Shanghai Health Study Update: October 31,2003 2003-10-29 bhrc technical minutes draft.doc Happy Halloween! Attached are updated draft minutes for Technical Committee members. This is an updated version compared to the set emailed to you from Bruce Jarnot earlier today (10/31). Please click on the following link, then click on "SHS Update" in the left hand navigation bar to view this week's update. http://www.shanghaihealthstudy.org Announcements: The Oversight Committee will be meeting on November 10th and 11th in San Francisco. The Technical Committee's next conference call is scheduled for Friday, November 7th at 2:00 pm EST. The Technical Committee draft minutes from 10/29 are posted for review on the Technical Committee page and attached to this email. If you have any announcements that you would like to be posted, please send an email to Matthew Todd, toddm@api.org. Matthew Todd Regulatory Analysis and Scientific Affairs American Petroleum Institute 1220 L Street NW Washington, DC 20005 p: (202)682-8319 f: (202)682-8031 www.api.org SH ELL-MCCLU RG-OS42S6 Benzene Health Research Consortium Draft Technical Committee Meeting Minutes October 29, 2003 API, Washington DC Participants 1. Patrick Beatty (ChevronTexaco) 2. Michael Bird (ExxonMobil) 3. Steve Bowes (ExxonMobil) 4. Bill Broddle (ConocoPhillips) 5. Stuart Cagen (Shell) 6. Patsy Clegg (Shell) 7. Bruce Jarnot (API) 8. Lorraine Twerdok (API) General Items Antitrust review and introductions were completed Shanghai-based "administrative manager" or "deputy director" for Richard Irons was discussed, as a means of reducing Consortium risk Otto Wong's request to reallocate travel funds, within AHS approved budget, was approved o ~~~iggttE13tyq~: communicate approval to Otto (completed 10/30103) 1.~~,grnttB~~tigl$1gtYr-ttE13tY~: resume monthly "progress checks" with Pis Contingency Fund Stuart proposed adding a $500K "contingency fund" line item to the budget Discussion supported both inclusion of a contingency fund, and the proposed size of the fund Endorsement of SRP Recommendations Two research enhancements proposed by the SRP were scientifically endorsed: o Addition of urinary SPMA analyses in ME study (link to earlier studies) o Addition of HIV testing of controls in CC study (a risk factor for NHL) Funding proposed by reducing # of ME workers from 2000 to 1000 o Michael reported possible funding interest by a EU biomarkers group; will consider at April 2004 meeting DRAFT Rev 10131103 Page 1 of 3 SH ELL-MCCLU RG-OS42S7 Benzene Health Research Consortium Draft Technical Committee Meeting Minutes Overall Budget Reconcilliation Investigator feedback suggested ME study could best withstand a "cut" in research budget; CC & DP studies should not be reduced Stuart recommended that an $800K reduction in ME budget be proposed o $500K toward contingency fund o $300K to fund added HIV testing (CC) & SPMA analyses (ME) o ,I,tH?O ... 8?triQk to review proposal wI Dr. Irons before next OC meeting o Proposal then goes to OC & SRP for review, endorsement Outreach to GOs & NGOs Stuart & Patrick suggested that the Consortium begin working "outreach" to both governmental (GOs) and non-governmental organizations (NGOs), such as the EPA and Leukemia Society Short term goal: active GO & NGO participation on the Technical Committee o EPA's Bob Sonowanee (sp?) had indicated desire to participate Longer term goal: possible GO & NGO financial support for the study A meeting at API was suggested to introduce GOs/NGOs to the study, scheduled about -6 months before the 2004 annual meeting (February?) Financial Operations API's CFO, Brenda Hargett, provided an overview of API financial operations, accounting practices and systems Recent development of system output, tailored to feed into the Consortium quarterly financial package, was highlighted Brenda indicated that API could contract an independent accounting review (or audit) of the University of Colorado grant, if desired o Cost estimated between $5-$25K, depending on scope and output DRAFT Rev 10131103 Page 20f3 SH ELL-MCCLU RG-OS42S8 Benzene Health Research Consortium Draft Technical Committee Meeting Minutes 3Q03 Financial Package Lorraine reviewed the format and content of the newly-developed quarterly financial report package, including rationale for budget projections ~q~iQnt-t..Qrr~iQ~ to recap Brenda's "API Financial Ops" presentation, and "Otrly Financial Report" format & content review at Nov 10/11 BHRC-OC mtg ~q~iQnl~~m$ were identified and requested to upgrade the report: o ~~~ new sheet detailing "UCHSC Subcontracts" for 4003 o ~~~ "comment flags" to identify source of data (e.g., budget values) o Rbjrjg~ cash flow statement to "actual" API expenses o ~~g line item for "Contingency Fund", when authorized o ItQQtOQt~ USHSC and T&E pages, indicating that "actual expenses" are from Progress Reports, and do not reflect grant payments o ,i~g "disbursement" or "grant payment" rows to Summary page o Move "Cash Flow Statement" to front section of book o P~'e~~ "names" column from Sponsor Payments sheet o $I"lrio~ width of columns to compress size of spreadsheets o ~r'mt 2-sided, on legal size paper Next Meeting A conference call was scheduled for Friday, Nov ih at 2:00pm EST DRAFT Rev 10131103 Page 30f3 SH ELL-MCCLU RG-OS42S9